, Volume 35, Issue 1-2, pp 72-78
Date: 08 Jan 2008

Advances in the Treatments of Systemic Vasculitides

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Necrotizing systemic vasculitides are severe diseases in which prognosis improved since steroids and cytotoxic agents have been prescribed. The outcome is now better, and remission is obtained in more than 80% of patients. In this review paper, we will cover the indications of conventional treatments and new biotherapies and other therapies. The strategies that improve patient’s outcome are discussed in the light of the prospective trials organized by international research groups.